Protected Drugs Represent More than 50% of Bayer Yakuhin Sales in 2012, Over 60% Eyed by 2014: Pres. Brunn

Bayer Yakuhin President Carsten Brunn Bayer Yakuhin derived more than 50% of its sales from patent-protected drugs in 2012 as the company successfully rolled out growth-driver products as planned, and it now aims to push up the ratio to over...read more